Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo

Diabetes Care

Volumn 28, Issue 9, 2005, Pages 2181-2186

  Schneider, Jochen G ^a,b   Von Eynatten, Maximilian ^a   Schiekofer, Stephan ^a   Nawroth, Peter P ^a   Dugi, Klaus A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; HEPARIN; INSULIN; LIVER TRIACYLGLYCEROL LIPASE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME ACTIVITY; HUMAN; IN VIVO STUDY; INFLAMMATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY;

ADIPONECTIN; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KINETICS; LIPASE; LIPIDS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REFERENCE VALUES; TRIGLYCERIDES;

EID: 24144446132     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.9.2181     Document Type: Article

References (39)

1. Zambon A, Austin MA, Brown BG, Hokanson JE, Brunzell JD: Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. Arterioscler Thromb 13:147-153, 1993
2. Cohen JC, Vega GL, Grundy SM: Hepatic lipase: new insights from genetic and metabolic studies. Curr Opin Lipidol 10:259-267, 1999
3. Perret B, Mabile L, Martinez L, Terce F, Barbaras R, Collet X: Hepatic lipase: structure/function relationship, synthesis, and regulation. J Lipid Res 43:1163-1169, 2002
4. Lewis GF, Murdoch S, Uffelman K, Naples M, Szeto L, Albers A, Adeli K, Brunzell JD: Hepatic lipase mRNA, protein, and plasma enzyme activity is increased in the insulin-resistant, fructose-fed Syrian golden hamster and is partially normalized by the insulin sensitizer rosiglitazone. Diabetes 53:2893-2900, 2004
5. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K: cDNA cloning and expression of a novel adipose specific collagen-like factor, apMl (AdiPose most abundant gene transcript 1). Biochem Biophys Res Commun 221:286-289, 1996
6. Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G: Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 52:1779-1785, 2003
7. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y: Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway. Circulation 102:1296-1301, 2000
8. Matsubara M, Maruoka S, Katayose S: Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 87:2764-2769, 2002
9. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79-83, 1999
10. Hotta K, Funahashi T, Bodkin NL, Onmeyer HK, Arita Y, Hansen BC, Matsuzawa Y: Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50:1126-1133, 2001
11. Laakso M, Sarlund H, Ehnholm C, Voutilainen E, Aro A, Pyorala K: Relationship between postheparin plasma lipases and high-density lipoprotein cholesterol in different types of diabetes. Diabetologia 30:703-706, 1987
12. Deeb SS, Zambon A, Carr MC, Ayyobi AF, Brunzell JD: Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet. J Lipid Res 44: 1279-1286, 2003
13. Sibley SD, Palmer JP, Hirsch IB, Brunzell JD: Visceral obesity, hepatic lipase activity, and dyslipidemia in type 1 diabetes. J Clin Endocrinol Metab 88:3379-3384, 2003
14. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762-769, 2003
15. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
16. Iverius PH, Brunzell JD: Human adipose tissue lipoprotein lipase: changes with feeding and relation to postheparin plasma enzyme. Am J Physiol 249:E107-E114, 1985
17. Cominacini L, Garbin U, Davoli A, Campagnola M, De Santis A, Pasini C, Pastorino AM, Bosello O: High-density lipoprotein cholesterol concentrations and postheparin hepatic and lipoprotein Upases in obesity: relationships with plasma insulin levels. Ann Nutr Metab 37: 175-184, 1993
18. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE: Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46:459-469, 2003
19. Purnell JQ, Kahn SE, Albers JJ, Nevin DN, Brunzell JD, Schwartz RS: Effect of weight loss with reduction of intra-abdominal fat on lipid metabolism in older men. J Clin Endocrinol Metab 85:977-982, 2000
20. Caixas A, Perez A, Payes A, Otal C, Carreras G, Ordonez-Llanos J, Reviriego J, Anderson JH, de Leiva A: Effects of a short-acting insulin analog (insulin lispro) versus regular insulin on lipid metabolism in insulin-dependent diabetes mellitus. Metabolism 47:371-376, 1998
21. Baynes C, Henderson AD, Richmond W, Johnston DG, Elkeles RS: The response of hepatic lipase and serum lipoproteins to acute hyperinsulinaemia in type 2 diabetes. Eur J Clin Invest 22:341-346, 1992
22. Ruotolo G, Parlavecchia M, Taskinen MR, Galimbeni G, Zoppo A, Le NA, Ragogna F, Micossi P, Pozza G: Normalization of lipoprotein composition by intraperitoneal insulin in IDDM: role of increased hepatic lipase activity. Diabetes Care 17: 6-12, 1994
23. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935, 2001
24. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Hiraoka H, Nakamura T, Funahashi T, Matsuzawa Y: Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23:85-89, 2003
25. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20:1595-1599, 2000
26. Semenkovich CF: Fatty acid metabolism and vascular disease. Trends Cardiovasc Med 14:72-76, 2004
27. Busch SJ, Barnhart RL, Martin GA, Flanagan MA, Jackson RL: Differential regulation of hepatic triglyceride lipase and 3-hydroxy-3-methylglutaryl-CoA reductase gene expression in a human hepatoma cell line, HepG2. J Biol Chem 265: 22474-22479, 1990
28. Botma GJ, van Deursen D, Vieira D, van Hoek M, Jansen H, Verhoeven AJM: Sterol-regulatory-element binding protein inhibits upstream stimulatory factor-stimulated hepatic lipase gene expression. Atherosclerosis 179:61-67, 2005
29. Shklyaev S, Aslanidi G, Tennant M, Prima V, Kohlbrenner E, Kroutov V, Campbell-Thompson M, Crawford J, Shek EW, Scarpace PJ, Zolotukhin S: Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats. Proc Natl Acad Sci USA 100:14217-14222, 2003
30. Ajuwon KM, Spurlock ME: Adiponectin inhibits LPS-induced NFκB activation and 1L-6 production, and increases PPARγ2 expression in adipocytes. Am J Physiol Regul lntegr Comp Physiol 288: 1220-1225, 2005
31. Zhu M, Miura J, Lu LX, Bernier M, De Cabo R, Lane MA, Roth GS, Ingram DK: Circulating adiponectin levels increase in rats on caloric restriction: the potential for insulin sensitization. Exp Gerontol 39: 1049-1059, 2004
32. Feingold KR, Memon RA, Moser AH, Shigenaga JK, Grunfeld C: Endotoxin and interleukin-1 decrease hepatic lipase mRNA levels. Atherosclerosis 142:379-387, 1999
33. Lihn AS, Bruun JM, He G, Pedersen SB, Jensen PF, Richelsen B: Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol 219:9-15, 2004
34. Boden WE: High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High-Density Lipoprotein Intervention Trial. Am J Cardiol 86:19L-22L, 2000
35. von Eynatten M, Schneider JG, Humpert PM, Rudofsky G, Schmidt N, Barosch P, Hamann A, Morcos M, Kreuzer J, Bierhaus A, Nawroth PP, Dugi KA: Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance. Diabetes Care 27:2925-2929, 2004
36. Zambon A, Deeb SS, Hokanson JE, Brown BG, Brunzell JD: Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol. Arterioscler Thromb Vasc Biol 18:1723-1729, 1998
37. Cheung MC, Sibley SD, Palmer JP, Oram JF, Brunzell JD: Lipoprotein lipase and hepatic lipase: their relationship with HDL subspecies Lp(A-I) and Lp(A-I,A-II). J Lipid Res 44:1552-1558, 2003
38. Lambert G, Chase MB, Dugi K, Bensadoun A, Brewer HB Jr, Santamarina-Fojo S: Hepatic lipase promotes the selective uptake of high density lipoprotein-cholesteryl esters via the scavenger receptor Bl. J Lipici Res 40:1294-1303, 1999
39. Collet X, Tall AR, Serajuddin H, Guendouzi K, Royer L, Oliveira H, Barbaras R, Jiang XC, Francone OL: Remodeling of HDL by CETP in vivo and by CETP and hepatic lipase in vitro results in enhanced uptake of HDL CE by cells expressing scavenger receptor B-I. J Lipid Res 40:1185-1193, 1999